Gleevec (imatinib)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Gleevec (imatinib), covering 2009-03-03 to 2015-07-23. Get the full timeline:
Most recent: Clinical Trial Update: Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 1]